Liberty Health Sciences Announces Independent Findings in Response to Short Seller Allegations and Further Strategic Changes

Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF), a provider of high quality cannabis, announced that it has received the report of its independent directors regarding allegations made by Hindenberg Research in its report dated December 6, 2018(the "Short Seller Report"). 

Investigation into Principal Allegations Contained in Short Seller Report

Liberty Health Sciences: A Budding MSO With Plenty Of Upside

The United States cannabis industry represents a significant growth opportunity and we have been monitoring the companies that are levered to this burgeoning market. During the last year, there has been a significant increase in the number of states that have legalized some form of legal cannabis and we are favorable on this trend.

Liberty Health Sciences Is Back On It's Feet and Ready To Expand In 2019

2018 was a banner year for the United States cannabis industry and 2019 will most likely be even more significant. During the last year, we have seen several significant medical cannabis markets open on the East Coast of the United States and we expect these markets to record massive growth going forward.

Liberty Health Sciences to Launch Zentient Labs CBD Portfolio of Products

Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com, a provider of high quality cannabis, today announced the launch of Zentient Labs, a line of premium hemp-based CBD products made from a proprietary formula of ultra-high quality CBD, nutraceuticals and vitamins that promote energy and focus for wellness seekers.

Pages